82
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cxc Chemokine Receptor 5 Expression Defines Follicular Homing T Cells with B Cell Helper Function

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Leukocyte traffic through secondary lymphoid tissues is finely tuned by chemokines. We have studied the functional properties of a human T cell subset marked by the expression of CXC chemokine receptor 5 (CXCR5). Memory but not naive T cells from tonsils are CXCR5 + and migrate in response to the B cell–attracting chemokine 1 (BCA-1), which is selectively expressed by reticular cells and blood vessels within B cell follicles. Tonsillar CXCR5 + T cells do not respond to other chemokines present in secondary lymphoid tissues, including secondary lymphoid tissue chemokine (SLC), EBV-induced molecule 1 ligand chemokine (ELC), and stromal cell–derived factor 1 (SDF-1). The involvement of tonsillar CXCR5 + T cells in humoral immune responses is suggested by their localization in the mantle and light zone germinal centers of B cell follicles and by the concomitant expression of activation and costimulatory markers, including CD69, HLA-DR, and inducible costimulator (ICOS). Peripheral blood CXCR5 + T cells also belong to the CD4 + memory T cell subset but, in contrast to tonsillar cells, are in a resting state and migrate weakly to chemokines. CXCR5 + T cells are very inefficient in the production of cytokines but potently induce antibody production during coculture with B cells. These properties portray CXCR5 + T cells as a distinct memory T cell subset with B cell helper function, designated here as follicular B helper T cells (T FH).

          Related collections

          Most cited references37

          • Record: found
          • Abstract: not found
          • Article: not found

          Chemokines: a new classification system and their role in immunity.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Lymphocyte homing and homeostasis.

            The integration and control of systemic immune responses depends on the regulated trafficking of lymphocytes. This lymphocyte "homing" process disperses the immunologic repertoire, directs lymphocyte subsets to the specialized microenvironments that control their differentiation and regulate their survival, and targets immune effector cells to sites of antigenic or microbial invasion. Recent advances reveal that the exquisite specificity of lymphocyte homing is determined by combinatorial "decision processes" involving multistep sequential engagement of adhesion and signaling receptors. These homing-related interactions are seamlessly integrated into the overall interaction of the lymphocyte with its environment and participate directly in the control of lymphocyte function, life-span, and population dynamics. In this article a review of the molecular basis of lymphocyte homing is presented, and mechanisms by which homing physiology regulated the homeostasis of immunologic resources are proposed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              International union of pharmacology. XXII. Nomenclature for chemokine receptors.

              Chemokine receptors comprise a large family of seven transmembrane domain G protein-coupled receptors differentially expressed in diverse cell types. Biological activities have been most clearly defined in leukocytes, where chemokines coordinate development, differentiation, anatomic distribution, trafficking, and effector functions and thereby regulate innate and adaptive immune responses. Pharmacological analysis of chemokine receptors is at an early stage of development. Disease indications have been established in human immunodeficiency virus/acquired immune deficiency syndrome and in Plasmodium vivax malaria, due to exploitation of CCR5 and Duffy, respectively, by the pathogen for cell entry. Additional indications are emerging among inflammatory and immunologically mediated diseases, but selection of targets in this area still remains somewhat speculative. Small molecule antagonists with nanomolar affinity have been reported for 7 of the 18 known chemokine receptors but have not yet been studied in clinical trials. Virally encoded chemokine receptors, as well as chemokine agonists and antagonists, and chemokine scavengers have been identified in medically important poxviruses and herpesviruses, again underscoring the importance of the chemokine system in microbial pathogenesis and possibly identifying specific strategies for modulating chemokine action therapeutically. The purpose of this review is to update current concepts of the biology and pharmacology of the chemokine system, to summarize key information about each chemokine receptor, and to describe a widely accepted receptor nomenclature system, ratified by the International Union of Pharmacology, that is facilitating clear communication in this area.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                4 December 2000
                : 192
                : 11
                : 1553-1562
                Affiliations
                [a ]Theodor-Kocher Institute, University of Bern, CH-3000 Bern 9, Switzerland
                [b ]BERNA, Swiss Serum and Vaccine Institute, 3018 Bern, Switzerland
                [c ]Molecular Tumorgenetics and Immunogenetics, Max-Delbrück Center for Molecular Medicine, 13092 Berlin, Germany
                Article
                001362
                10.1084/jem.192.11.1553
                2193097
                11104798
                c8b1de20-fa0c-41d0-9635-2e03054f4427
                © 2000 The Rockefeller University Press
                History
                : 9 August 2000
                : 5 October 2000
                : 9 October 2000
                Categories
                Original Article

                Medicine
                cxc chemokine receptor 5,chemokines,b cell follicle,lymphocytes,antibodies
                Medicine
                cxc chemokine receptor 5, chemokines, b cell follicle, lymphocytes, antibodies

                Comments

                Comment on this article